Impaired fasting glucose is comparable to diabetes mellitus in predicting mortality and cardiovascular events in patients undergoing peritoneal dialysis: the role of beta-cell function and insulin resistance
Ren Fail. 2026 Dec;48(1):2692758. doi: 10.1080/0886022X.2026.2692758. Epub 2026 Jul 5.ABSTRACTPeritoneal dialysis (PD) disrupts glucose metabolism due to repeated exposure to glucose-based dialysate. This prospective cohort study evaluates whether impaired fasting glucose (IFG) confers cardiovascula

